In patients presenting with one major endocrine manifestation of MEN1, the presence of cutaneous lesions, i.e., angiofibromas and lipomas, might suggest the diagnosis of MEN1 and a possible indication of genetic screening. This evidence concerns the gene MEN1 and Angiofibromas.